Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study-Reference-Cited by-同舟云学术

Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study

Published:2023-12 Issue:12 Volume:23 Page:882-888
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Htut Myo^ORCID,Dhakal Binod,Cohen Adam D.^ORCID,Martin Thomas,Berdeja Jesus G.^ORCID,Usmani Saad Z.,Agha Mounzer,Jackson Carolyn C.,Madduri Deepu,Deraedt William^ORCID,Zudaire Enrique,Yeh Tzu-min,Xu Xiaoying,Pacaud Lida,Akram Muhammad,Jagannath Sundar^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. Current status of autologous stem cell transplantation for multiple myeloma;Al Hamed;Blood Cancer J,2019

2. Autologous stem-cell transplantation for multiple myeloma in the era of novel therapies;Parrondo;JCO Oncol Pract,2020

3. Long-term outcome after allogeneic stem cell transplantation in multiple myeloma;Luoma;Ann Hematol,2021

4. The graft-versus-myeloma effect: chronic graft-versus-host disease but not acute graft-versus-host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantation;Donato;Biol Blood Marrow Transplant,2014

5. Allogeneic stem cell transplantation in multiple myeloma;Greil;Cancers (Basel),2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Risk of Infection in Patients With Multiple Myeloma Treated With T-Cell Redirecting Approaches: A Call Out for Clinicians;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee;The Lancet Oncology;2024-08

4. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

5. The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma;Expert Opinion on Drug Discovery;2024-02-18